The Commission also indicated that although the US government is reviewing its stance on foreign aid, Uganda stands to lose ...
An annual injection designed to guard against Human Immunodeficiency Virus (HIV) has completed an important early safety ...
Malaria season kicks off this month across much of Africa. This disease remains the deadliest on the continent, particularly affecting children. The decision by the Trump administration to cut 90% ...
Copyright 2025 The Associated Press. All Rights Reserved. FILE- A woman waits to have the malaria vaccine R21/Matrix-M administered to her child at the comprehensive ...
The Lagos State Government has announced a plan to reduce malaria prevalence below 1% through the launch of the Pathway to Malaria Pre-Elimination & Digitization Program. According to the State, it’s ...
Get Instant Summarized Text (Gist) A large-scale analysis highlights the critical steps to combat vertical transmission of hepatitis B in Africa, where two-thirds of new global infections occur ...
A new clinical trial from Scripps Research in La Jolla aims to make significant gains in the global fight against malaria by making a drug that has been around since the 1970s last longer.
With malaria being one of the most significant causes of morbidity and mortality worldwide, prompt and effective treatment is essential to reduce the malaria burden. As there are several treatment ...
LONDON, Feb 21 (Reuters) - The U.S. government's foreign aid freeze has upended the supply chain for medical products crucial for fighting diseases including HIV and malaria in some of the world's ...
ARAKODA is an antimalarial indicated for the prophylaxis of malaria in patients aged 18 years and older in the United States (U.S.) It is sold under the brand name KODATEF in Australia, where it is ...
Zuhumnan said that prophylaxis was administered to children under five years of age without malaria to boost their iimmunities and prevent them from coming down with the disease. He said that the ...
In this week's PLoS Medicine, Teun Bousema of the London School of Hygiene & Tropical Medicine, UK and colleagues argue that targeting malaria "hotspots," small groups of households at a substantially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results